Endovia Health Sciences, Inc. EDVA
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -87.96% | -89.54% | -84.30% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -87.96% | -89.54% | -84.30% |
| Cost of Revenue | -- | -- | -46.08% | -79.84% | -79.16% |
| Gross Profit | -- | -- | -233.78% | -122.21% | -101.11% |
| SG&A Expenses | -- | -- | 45.55% | 31.35% | -27.97% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | -- | 37.66% | 3.34% | -44.33% |
| Operating Income | -- | -- | -47.83% | -48.40% | 15.71% |
| Income Before Tax | -- | -- | -38.28% | -47.57% | -17.25% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -- | -- | -38.28% | -47.57% | -17.25% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -- | -6.22% | -50.01% | -19.58% |
| EBIT | -- | -- | -47.83% | -48.40% | 15.71% |
| EBITDA | -- | -- | -53.98% | -53.55% | 14.37% |
| EPS Basic | -- | -- | 37.88% | 3.11% | 16.88% |
| Normalized Basic EPS | -- | -- | 40.66% | 20.06% | 34.64% |
| EPS Diluted | -- | -- | 37.88% | 3.11% | 16.88% |
| Normalized Diluted EPS | -- | -- | 40.66% | 20.06% | 34.64% |
| Average Basic Shares Outstanding | -- | -- | 62.03% | 56.04% | 45.90% |
| Average Diluted Shares Outstanding | -- | -- | 62.03% | 56.04% | 45.90% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |